HCA Healthcare Reports 8.7% Revenue Growth to $20.230 Billion in Q2 2026

HCA Healthcare, Inc. reported significant financial growth in its second quarter of 2026, with revenues reaching $20.230 billion, an increase of 8.7% from $18.605 billion in the same quarter of 2025. The company's net income attributable to HCA Healthcare rose to $1.699 billion, or $7.62 per diluted share, compared to $1.653 billion, or $6.83 per diluted share, in the prior year. The increase in revenue was driven by a 6.0% rise in revenue per equivalent admission and a 2.6% increase in equivalent admissions. The results also included gains on sales of facilities amounting to $10 million for the quarter, contrasting with losses of $3 million in the previous year.

In the first six months of 2026, HCA Healthcare's revenues totaled $39.339 billion, up from $36.926 billion in the same period of 2025, marking a 6.5% increase. Net income for the first half of 2026 was $3.319 billion, or $14.77 per diluted share, compared to $3.263 billion, or $13.28 per diluted share, in the prior year. The company attributed the revenue growth to a combination of a 4.6% increase in revenue per equivalent admission and a 1.9% rise in equivalent admissions. The increase in revenues was also influenced by Medicaid state directed and supplemental payment programs, particularly from the Florida directed payment program.

Operationally, HCA Healthcare experienced a 2.4% increase in consolidated admissions and a 2.5% increase in same facility admissions compared to the second quarter of 2025. However, inpatient surgical volumes declined by 2.3%, and outpatient surgical volumes decreased by 4.4%. Emergency department visits increased by 3.5%, indicating a shift in patient care dynamics. The company also reported a notable increase in uninsured admissions, which rose by 23.3% for the quarter, reflecting the impact of the expiration of enhanced premium tax credits and administrative reforms affecting insurance purchased through exchanges.

HCA Healthcare's total uncompensated care for the quarter was $15.076 billion, up from $11.625 billion in the previous year, with an estimated cost of $1.445 billion compared to $1.116 billion in 2025. The company continues to navigate challenges related to rising operational costs, with salaries and benefits as a percentage of revenues decreasing to 41.0% from 43.7% year-over-year. Other operating expenses increased to 24.9% of revenues, primarily due to growth in Medicaid-related expenses and inflationary pressures.

Looking ahead, HCA Healthcare anticipates continued revenue growth driven by strategic initiatives and operational efficiencies. The company plans to maintain its focus on capital expenditures, with expected spending between $5.0 billion and $5.5 billion in 2026, excluding acquisitions. HCA Healthcare remains committed to enhancing its service offerings and expanding its geographic footprint while managing the complexities of the healthcare landscape, including regulatory changes and market conditions.